ACM Biosciences AG
0 followers
ACM Biosciences AG was established in Basel, Switzerland in September 2020. It is dedicated to the development of infectious disease vaccines using it's proprietary ACM polymersome platform technology. Its current primary focus is to get a safe, effective and highly manufacturable COVID-19 vaccine t... Read more
Org chart
Henric Bjarke
Chief Executive Officer
Henric Bjarke
Collapse
Michael Mauch
Head Project Management ACM Biosciences AG
Katherine Schultheis
Head Discovery Research
